CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 29 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354 | +28.7% | 188,164 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $275 | -24.9% | 188,164 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $366 | -13.3% | 188,164 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $422 | -99.9% | 188,164 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $451,000 | +15.6% | 188,164 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $390,000 | -26.3% | 188,164 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $529,000 | -22.5% | 188,243 | +27.8% | 0.00% | -33.3% |
| Q4 2021 | $683,000 | +59.2% | 147,294 | -9.2% | 0.00% | +50.0% |
| Q3 2021 | $429,000 | -10.6% | 162,217 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $480,000 | -9.3% | 168,406 | -3.8% | 0.00% | 0.0% |
| Q1 2021 | $529,000 | +70.6% | 175,015 | +66.7% | 0.00% | +100.0% |
| Q4 2020 | $310,000 | -8.6% | 105,018 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $339,000 | -1.5% | 105,018 | +2.3% | 0.00% | 0.0% |
| Q2 2020 | $344,000 | +2.7% | 102,618 | +10.8% | 0.00% | -50.0% |
| Q1 2020 | $335,000 | -33.8% | 92,643 | -5.7% | 0.00% | 0.0% |
| Q4 2019 | $506,000 | -15.8% | 98,192 | -3.0% | 0.00% | -33.3% |
| Q3 2019 | $601,000 | -9.6% | 101,280 | -3.1% | 0.00% | 0.0% |
| Q2 2019 | $665,000 | +17.5% | 104,498 | +6.9% | 0.00% | +50.0% |
| Q1 2019 | $566,000 | -3.7% | 97,733 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $588,000 | +5.2% | 97,733 | 0.0% | 0.00% | +50.0% |
| Q3 2018 | $559,000 | -15.8% | 97,733 | -9.9% | 0.00% | -33.3% |
| Q2 2018 | $664,000 | -7.5% | 108,486 | +1.1% | 0.00% | 0.0% |
| Q1 2018 | $718,000 | -23.0% | 107,322 | -15.4% | 0.00% | -25.0% |
| Q4 2017 | $933,000 | +2.9% | 126,797 | -1.3% | 0.00% | 0.0% |
| Q3 2017 | $907,000 | -0.4% | 128,427 | -1.3% | 0.00% | 0.0% |
| Q2 2017 | $911,000 | +0.7% | 130,073 | -0.3% | 0.00% | 0.0% |
| Q1 2017 | $905,000 | +30.8% | 130,430 | +3.4% | 0.00% | +33.3% |
| Q4 2016 | $692,000 | +3.7% | 126,173 | -5.5% | 0.00% | 0.0% |
| Q3 2016 | $667,000 | +8.8% | 133,477 | -2.0% | 0.00% | 0.0% |
| Q2 2016 | $613,000 | +0.3% | 136,201 | +0.1% | 0.00% | 0.0% |
| Q1 2016 | $611,000 | -31.3% | 136,084 | -19.2% | 0.00% | -40.0% |
| Q4 2015 | $889,000 | -11.6% | 168,518 | -3.4% | 0.01% | 0.0% |
| Q3 2015 | $1,006,000 | -19.4% | 174,484 | +0.1% | 0.01% | -16.7% |
| Q2 2015 | $1,248,000 | +127.7% | 174,355 | +111.5% | 0.01% | +100.0% |
| Q1 2015 | $548,000 | +238.3% | 82,455 | +202.5% | 0.00% | +200.0% |
| Q4 2014 | $162,000 | +20.0% | 27,259 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $135,000 | -4.3% | 27,259 | -12.8% | 0.00% | 0.0% |
| Q2 2014 | $141,000 | -5.4% | 31,250 | -5.3% | 0.00% | 0.0% |
| Q1 2014 | $149,000 | -25.5% | 33,013 | -15.5% | 0.00% | 0.0% |
| Q4 2013 | $200,000 | +13.0% | 39,061 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $177,000 | – | 39,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Financial Planning, Inc. | 22,031 | $46,000 | 0.03% |
| BERKSHIRE ASSET MANAGEMENT LLC/PA | 189,048 | $392,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $595,000 | 0.01% |
| Renaissance Technologies | 622,228 | $1,291,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $390,000 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $6,000 | 0.00% |
| BlackRock Inc. | 140,248 | $292,000 | 0.00% |
| Citadel Advisors | 32,300 | $67,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,900 | $60,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 34,592 | $72,000 | 0.00% |